Walleye Capital LLC Organon & Co. Call Options Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$18.65 - $23.03 $1,864 - $2,303	-100 Reduced 0.14%	73,500 $1.41 Million
Q2 2024 Aug 14, 2024	SELL	$17.45 - $21.96 $507,795 - $639,036	-29,100 Reduced 28.33%	73,600 $1.52 Million
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $180,518 - $246,280	13,100 Added 14.62%	102,700 $1.93 Million
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $809,205 - $1.28 Million	73,900 Added 470.7%	89,600 $1.29 Million
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $58,065 - $83,195	-3,500 Reduced 18.23%	15,700 $272,000
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $159,941 - $204,429	8,300 Added 76.15%	19,200 $399,000
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $12,852 - $19,248	600 Added 5.83%	10,900 $256,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $27,972 - $34,332	-1,200 Reduced 10.43%	10,300 $287,000
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $269,100 - $393,875	11,500 New	11,500 $269,000

790

204M

1.71M

870K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.